At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PBM Psyence Biomedical Ltd
Pre-Market Trading 11-22 08:44:07 EST
0.0470
-0.0030
-6.00%
盘前0.0479
+0.0009+1.91%
08:42 EST
High0.0500
Low0.0440
Vol7.70M
Open0.0500
D1 Closing0.0500
Amplitude12.00%
Mkt Cap2.98M
Tradable Cap2.34M
Total Shares63.38M
T/O354.77K
T/O Rate15.49%
Tradable Shares49.71M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules
Psyence Biomedical Announces Results From Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination From Nasdaq
Press Release: Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq
Psyence Group's Nasdaq-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase Iib Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.